Archive ready

大正製薬株式会社に対する景品表示法に基づく措置命令について | 消費者庁

https://www.caa.go.jp/notice/entry/039990/

April 6, 2026 at 09:31 AM JST•The archive page, viewer, and downloads use this saved version.

April 6, 2026 at 09:31 AM JST·www.caa.go.jp

The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.

Saved page

大正製薬株式会社に対する景品表示法に基づく措置命令について | 消費者庁

Open the archived HTML with saved-time metadata attached.

Original URLhttps://www.caa.go.jp/notice/entry/039990/

StartedApril 6, 2026 at 09:31 AM JST

This HTML has CSS and images embedded, so it can still be opened even if the original page disappears.

About this pageAI generated

This page announces an administrative order issued by the Consumer Affairs Agency on November 13, 2024, against Taisho Pharmaceutical Co., Ltd. The company's supplement product "NMN taisho" was found to violate the Act against Unjustifiable Premiums and Misleading Representations through stealth marketing practices under Article 5, Paragraph 3. An order was issued based on Article 7, Paragraph 1 of the Act. Detailed information is available in the published PDF document.

Screenshot

The full page can be captured up to 15,000px in height so you can review the complete page layout when needed.